Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Berke

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|December 1, 2005
Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue cultureJan Martin Berke, Darius Moradpour
The Journal of General Virology|October 22, 2008
Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virusJingmin Ji, Andrea Glaser, Marion Wernli, et al.
Journal of Virology|May 28, 2005
Characterization of nonstructural protein membrane anchor deletion mutants expressed in the context of the hepatitis C virus polyproteinRainer Gosert, Wiebke Jendrsczok, Jan Martin Berke, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2008
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complexVolker Brass, Jan Martin Berke, Roland Montserret, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379Jan Martin Berke, Pascale Dehertogh, Karen Vergauwen, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2013
A cellular replicon-based phenotyping assay to determine susceptibility of hepatitis C virus clinical isolates to NS3/4A protease inhibitorsLeen Vijgen, Jannick Verbeeck, Barbara Van Kerckhove, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B VirusJan Martin Berke, Pascale Dehertogh, Karen Vergauwen, et al.
Journal of Virology|November 25, 2005
Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1Francois H T Duong, Verena Christen, Jan Martin Berke, et al.
Antiviral Research|June 26, 2017
Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitroJan Martin Berke, Ying Tan, Thierry Verbinnen, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life CycleThomas Lahlali, Jan Martin Berke, Karen Vergauwen, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|December 1, 2005
Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue cultureJan Martin Berke, Darius Moradpour
The Journal of General Virology|October 22, 2008
Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virusJingmin Ji, Andrea Glaser, Marion Wernli, et al.
Journal of Virology|May 28, 2005
Characterization of nonstructural protein membrane anchor deletion mutants expressed in the context of the hepatitis C virus polyproteinRainer Gosert, Wiebke Jendrsczok, Jan Martin Berke, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2008
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complexVolker Brass, Jan Martin Berke, Roland Montserret, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379Jan Martin Berke, Pascale Dehertogh, Karen Vergauwen, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2013
A cellular replicon-based phenotyping assay to determine susceptibility of hepatitis C virus clinical isolates to NS3/4A protease inhibitorsLeen Vijgen, Jannick Verbeeck, Barbara Van Kerckhove, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B VirusJan Martin Berke, Pascale Dehertogh, Karen Vergauwen, et al.
Journal of Virology|November 25, 2005
Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1Francois H T Duong, Verena Christen, Jan Martin Berke, et al.
Antiviral Research|June 26, 2017
Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitroJan Martin Berke, Ying Tan, Thierry Verbinnen, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life CycleThomas Lahlali, Jan Martin Berke, Karen Vergauwen, et al.
Pageof 4